Citation:Hughes MJ, Chowdhry MF, Woolley SM, Walker WS 2011

From Cancer Guidelines Wiki

Citation


Hughes MJ, Chowdhry MF, Woolley SM, Walker WS. In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior? Interact Cardiovasc Thorac Surg 2011 Sep;13(3):311-5 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21606053.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Hughes MJ, Chowdhry MF, Woolley SM, Walker WS 2011What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?Associate Professor Gavin Wright MD FRACS PhDcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of mediastinal lymph node dissection in stage IIIA operable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Hughes_MJ,_Chowdhry_MF,_Woolley_SM,_Walker_WS_2011&oldid=21191"